DJIA 17,071.22 -41.93 -0.25%
NASDAQ 4,505.85 -6.34 -0.14%
S&P 500 1,977.80 -5.05 -0.25%
market minute promo

Eli Lilly & Co. (NYSE: LLY)

65.34 -0.14 (-0.21%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LLY $65.34 -0.21%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $65.06
Previous Close $65.48
Daily Range $64.83 - $65.45
52-Week Range $47.53 - $67.14
Market Cap $73.0B
P/E Ratio 20.79
Dividend (Yield) $1.96 (3.0%)
Ex-Dividend Date
Dividend Pay Date
08/13/14
09/10/14
Volume 3,520,571
Average Daily Volume 3,613,093
Current FY EPS $2.79

Sector

Healthcare

Industry

Drugs

Eli Lilly & Co. (LLY) Description

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases. Website: http://www.lilly.com/

News & Commentary

3 Reasons Eli Lilly & Co.'s Stock Could Fall

Management at Eli Lilly & Co. has faced a mountain of challenges in the wake of debilitating patent losses, but the stock has held strong regardless. Here are three reasons that rally may not continue into the future.

Pharma Stocks: Surprising Shift In U.S. Drug Market

2 Reasons Why Eli Lilly's New Diabetes Drug Might Not Become A Blockbuster

AstraZeneca Posts Positive Data on its Type II Diabetes Drug - Analyst Blog

Boehringer aims to cut up to 600 jobs in Germany

Eli Lilly: A Full Suite Of Offerings For Diabetic Patients

Dyax Offers Highlights of Recent Progress in Licensing, Funded-Research Portfolio

Week In Review: GSK Ends China Bribery Investigation By Paying $489 Million Fine

Eli Lilly's Trulicity Approved by FDA for Type II Diabetes - Analyst Blog

Dow Chemical (DOW) Gets Key USDA Nod for Enlist Traits - Analyst Blog

Dow Chemical (DOW) Gets Key USDA Nod for Enlist Traits - Analyst Blog

See More LLY News...

LLY's Top Competitors

LLY $65.34 (-0.21%)
Current stock: LLY
JNJ $106.54 (-0.52%)
Current stock: JNJ
PFE $29.77 (0.17%)
Current stock: PFE
RHHBY $36.90 (-0.24%)
Current stock: RHHBY